Saba Capital Management, L.P. sold HQL

January 31, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 15,143 shares of Abrdn Life Sciences Investors at $14.27 per share, a transaction worth $216.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.